Efficacy of Allogenic Stem Cell Transplant in KMT2A Partial Tandem Duplication ( -PTD) Myeloid Neoplasms

Puntos clave

• Efficacy of allogenic stem cell transplant shows promise in treating myeloid neoplasms associated with KMT2A alterations.
• Patients with KMT2A partial tandem duplication may respond positively to this transplant approach, enhancing survival.
• Assessment based on patient records indicates significant outcomes following intervention over a specified follow-up period.
• Findings highlight the need for further exploration into stem cell interventions for specific myeloid neoplasms.